EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma

Majid Ghasemian iD, Hossein Babaahmadi-Rezaei, Azam Khedri, Chandrabose Selvaraj

Journal of Cellular and Molecular Medicine · 2023-12 · 27 (24) · 3966-3973

DOI: 10.1111/jcmm.17978 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.09.2023. Verfasst von Majid Ghasemian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Melanoma, RNA, Long Noncoding. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LncRNA Survival Associated Mitochondrial Melanoma Specific Oncogenic Non‐coding RNA (SAMMSON) is located on human chromosome 3p13, and its expression is upregulated in several tumours, including melanoma, breast cancer, glioblastoma and liver cancer and has an oncogenic role in malignancy disorders. It has been reported that SAMMSON impacts metabolic regulation, cell proliferation, apoptosis, EMT, drug resistance, invasion and migration. Also, SAMMSON is involved in regulating several pathways such as Wnt, MAPK, PI3K, Akt, ERK and p53. SAMMSON is considered a potential diagnostic and prognostic biomarker in several types of cancer and a suitable therapeutic target. In addition, the highly expressed SAMMSON is closely associated with clinicopathological features of various cancers. SAMMSON has a significant role in regulating epigenetic processes by regulating histone protein or the status of DNA methylation. Herein for the first time, we comprehensively summarized the currently available SAMMSON, molecular regulatory pathways, and clinical significance. We believe that clarifying all the molecular aspects of this lncRNA can be a good guide for cancer studies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaRNA, Long NoncodingHumansCell Transformation, NeoplasticCarcinogenesisHistonesCell ProliferationGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

LncRNASAMMSONcancerepigeneticsignalling pathway

Substanzen

RNA, Long NoncodingHistones

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

ORCID-Profile: Majid Ghasemian

Zitieren

APA

Ghasemian, M., Babaahmadi-Rezaei, H., Khedri, A., & Selvaraj, C. (2023). The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma. Journal of Cellular and Molecular Medicine, 27(24), 3966-3973. https://doi.org/10.1111/jcmm.17978

Vancouver

Ghasemian M, Babaahmadi-Rezaei H, Khedri A, Selvaraj C. The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma. Journal of Cellular and Molecular Medicine. 2023;27(24):3966-3973. doi:10.1111/jcmm.17978

BibTeX
@article{Ghasemian2023,
  author = {Ghasemian, Majid and Babaahmadi-Rezaei, Hossein and Khedri, Azam and Selvaraj, Chandrabose},
  title = {The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  volume = {27},
  number = {24},
  pages = {3966--3973},
  doi = {10.1111/jcmm.17978}
}
Kostenlos starten →